Xenon Pharmaceuticals (XENE) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Xenon Pharmaceuticals (XENE) over the last 13 years, with Q3 2025 value amounting to -$9.5 million.
- Xenon Pharmaceuticals' Other Gross PP&E Adjustments rose 350.23% to -$9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.5 million, marking a year-over-year increase of 350.23%. This contributed to the annual value of $2.9 million for FY2024, which is 17485.95% up from last year.
- According to the latest figures from Q3 2025, Xenon Pharmaceuticals' Other Gross PP&E Adjustments is -$9.5 million, which was up 350.23% from -$8.0 million recorded in Q2 2025.
- In the past 5 years, Xenon Pharmaceuticals' Other Gross PP&E Adjustments registered a high of $2.9 million during Q4 2024, and its lowest value of -$10.9 million during Q1 2023.
- Its 5-year average for Other Gross PP&E Adjustments is -$6.8 million, with a median of -$8.5 million in 2022.
- Per our database at Business Quant, Xenon Pharmaceuticals' Other Gross PP&E Adjustments plummeted by 127188.94% in 2022 and then soared by 17485.95% in 2024.
- Xenon Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$217000.0 in 2021, then plummeted by 1271.89% to -$3.0 million in 2022, then crashed by 31.47% to -$3.9 million in 2023, then skyrocketed by 174.86% to $2.9 million in 2024, then crashed by 423.48% to -$9.5 million in 2025.
- Its Other Gross PP&E Adjustments was -$9.5 million in Q3 2025, compared to -$8.0 million in Q2 2025 and -$9.2 million in Q1 2025.